Connexin 32 downregulation is critical for chemoresistance in oxaliplatin-resistant HCC cells associated with EMT

Background: Oxaliplatin (OXA)-based chemotherapy is critical in the management of advanced hepatocellular carcinoma (HCC); however, acquired drug resistance has largely restricted its clinical efficacy. This study aims to explore the key mechanisms and regulatory factors determining chemosensitivity...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yan, Yao, Jing-Hao, Du, Qian-Yu, Zhou, Yong-Chun, Yao, Ting-Jing, Wu, Qiong, Liu, Jing, Ou, Yu-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549660/
https://www.ncbi.nlm.nih.gov/pubmed/31213923
http://dx.doi.org/10.2147/CMAR.S203656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549660/
https://www.ncbi.nlm.nih.gov/pubmed/31213923
http://dx.doi.org/10.2147/CMAR.S203656

Ejemplares similares